Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda Medical Dialogues Bureau9 Oct 2019 10:54 AM GMTJohnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...